Dipharma Francis S.r.l. Sustainability Profile
Dipharma Francis S.r.l., headquartered in Italy, is a prominent player in the pharmaceutical industry, specialising in the development and manufacturing of active pharmaceutical ingredients (APIs) and intermediates. Founded in 1946, the company has established a strong presence in Europe and beyond, focusing on high-quality products tailored for the global market. With a commitment to innovation, Dipharma offers a diverse range of services, including custom synthesis and contract manufacturing, which set it apart from competitors. The company is recognised for its expertise in complex chemical processes and its dedication to sustainability. Over the years, Dipharma has achieved significant milestones, solidifying its market position as a trusted partner for pharmaceutical companies worldwide.
DitchCarbon Score
How does Dipharma Francis S.r.l.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Dipharma Francis S.r.l.'s score of 9 is lower than 79% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Dipharma Francis S.r.l.'s reported carbon emissions
Dipharma Francis S.r.l., headquartered in Italy, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments to reducing its carbon footprint at this time. As a current subsidiary, any potential climate initiatives or emissions data may be influenced by the broader corporate strategies of its parent organisation. However, no specific initiatives or targets have been cascaded from the parent company that could provide insight into Dipharma's climate commitments. In the context of the pharmaceutical industry, companies are increasingly expected to adopt robust climate strategies and transparency in emissions reporting. Without specific data or commitments, Dipharma Francis S.r.l. may face challenges in aligning with industry standards and stakeholder expectations regarding sustainability and climate action.
How Carbon Intensive is Dipharma Francis S.r.l.'s Industry?
How Carbon Intensive is Dipharma Francis S.r.l.'s Location?
Dipharma Francis S.r.l.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Dipharma Francis S.r.l. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
